Cardiovascular Risks Mount with Certain Anti-Inflammatory Drugs

Cardiovascular Risks Mount with Certain Anti-Inflammatory Drugs

By
estaff
-
Published:
0
A recent analysis of data from more than a million users of nonsteroidal anti-inflammatory drugs (NSAIDs) underscores the importance of careful selection and use of the medications, because they can vary widely in the risks they pose to patients. In the cohort study out of Denmark, the use of diclofenac (Cataflam, Voltaren) was associated with a 91 percent increase in the relative risk of a fatal heart attack or stroke in healthy adults.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access

RELATED ARTICLESMORE FROM AUTHOR